Leica Biosystems Nussloch GmbH - Product Pipeline Analysis, 2019 Update

Summary

Leica Biosystems Nussloch Gmbh (Leica Biosystems) is a medical device company. The company provides histology and anatomical pathology workflow solutions. It offers histology equipment and consumables; immuo histochemistry, in situ hybridization, and fluorescence in situ hybridization (FISH); digital pathology; clinical microscopy, surgery, and radiology products; and research products. Leica Biosystems’ histology equipment includes tissue processors, microtomes, sliding and vibrating blade microtomes, microtomes accessories, cryostats, embedding center modules and accessories, and sample tracking system. The company also provides field and technical support, and training services. Leica Biosystems is headquartered in Nussloch, Baden-Wurttemberg, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Leica Biosystems Nussloch GmbH
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Leica Biosystems Nussloch GmbH Company Overview
Leica Biosystems Nussloch GmbH Company Snapshot
Leica Biosystems Nussloch GmbH Pipeline Products and Ongoing Clinical Trials Overview
Leica Biosystems Nussloch GmbH – Pipeline Analysis Overview
Leica Biosystems Nussloch GmbH - Key Facts
Leica Biosystems Nussloch GmbH - Major Products and Services
Leica Biosystems Nussloch GmbH Pipeline Products by Development Stage
Leica Biosystems Nussloch GmbH Pipeline Products Overview
Aperio LV1
Aperio LV1 Product Overview
Companion Diagnostic Assay - Seribantumab
Companion Diagnostic Assay - Seribantumab Product Overview
Companion Diagnostic Assay - Solid Tumor
Companion Diagnostic Assay - Solid Tumor Product Overview
Companion Diagnostic Test For Targeted Cancer Therapies
Companion Diagnostic Test For Targeted Cancer Therapies Product Overview
Neuvax Companion Diagnostic Assay
Neuvax Companion Diagnostic Assay Product Overview
RNAscope Based Companion Diagnostic Test
RNAscope Based Companion Diagnostic Test Product Overview
RNAscope Based Diagnostic Test
RNAscope Based Diagnostic Test Product Overview
Leica Biosystems Nussloch GmbH - Key Competitors
Leica Biosystems Nussloch GmbH - Key Employees
Leica Biosystems Nussloch GmbH - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Leica Biosystems Nussloch GmbH, Recent Developments
May 29, 2019: Leica Biosystems receives FDA 510(k) clearance to market a digital pathology system for primary diagnosis
Jan 08, 2019: Leica Biosystems receives US patent for RTF Extreme Speed Scanning Technology
Nov 13, 2018: A new PD-L1 BOND Ready-to-Use antibody, providing you with the freedom and flexibility to develop the tests you need
Oct 02, 2018: For Breast Biopsies, MammoPort Standardizes Tissue Transfer from Radiology to Pathology to Ensure Quality and Reduce Errors
Sep 18, 2018: For high-volume pathology labs, HistoCore SPECTRA Workstation delivers immediately dry slides at faster turnaround times
Jul 31, 2018: Leica Biosystems Aperio LV1 IVD rpproved For Remote frozen Section and telepathology
Jun 19, 2018: Leica Biosystems Introduces the Next-gen BOND RX IHC, ISH and Emerging Tests Stainer
May 30, 2018: Rotary Microtome Solutions Provide Pathology Labs High Quality Sectioning and Enhanced User Safety
Apr 12, 2018: Leica Biosystems Showcases Aperio Digital Pathology Scanners and Image Analysis Algorithms at American Association of Cancer Research Annual Meeting
Feb 01, 2018: Aiming to improve pathology lab management leica biosystems builds on advanced staining legacy with next gen BOND-III IHC and ISH stainer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Leica Biosystems Nussloch GmbH Pipeline Products and Ongoing Clinical Trials Overview
Leica Biosystems Nussloch GmbH Pipeline Products by Equipment Type
Leica Biosystems Nussloch GmbH Pipeline Products by Indication
Leica Biosystems Nussloch GmbH, Key Facts
Leica Biosystems Nussloch GmbH, Major Products and Services
Leica Biosystems Nussloch GmbH Number of Pipeline Products by Development Stage
Leica Biosystems Nussloch GmbH Pipeline Products Summary by Development Stage
Aperio LV1 - Product Status
Aperio LV1 - Product Description
Companion Diagnostic Assay - Seribantumab - Product Status
Companion Diagnostic Assay - Seribantumab - Product Description
Companion Diagnostic Assay - Solid Tumor - Product Status
Companion Diagnostic Assay - Solid Tumor - Product Description
Companion Diagnostic Test For Targeted Cancer Therapies - Product Status
Companion Diagnostic Test For Targeted Cancer Therapies - Product Description
Neuvax Companion Diagnostic Assay - Product Status
Neuvax Companion Diagnostic Assay - Product Description
RNAscope Based Companion Diagnostic Test - Product Status
RNAscope Based Companion Diagnostic Test - Product Description
RNAscope Based Diagnostic Test - Product Status
RNAscope Based Diagnostic Test - Product Description
Leica Biosystems Nussloch GmbH, Key Employees
Leica Biosystems Nussloch GmbH, Subsidiaries
Glossary
List of Figures
Leica Biosystems Nussloch GmbH Pipeline Products by Equipment Type
Leica Biosystems Nussloch GmbH Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook